Atlas Trials

Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification

Clinical trial NCT03813771 · UNKNOWN

Trial details

NCT number
NCT03813771
Sponsor
University of Leeds
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2019-03-01
Primary completion
2023-02-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.